Login Register
icon_bulk_orderBulk order Acrobiosystems for English
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > GM-CSF

GM-CSF

Brief Information

Name:Macrophage colony stimulating factor 2
Target Synonym:GM-CSF,Molgramostin,CSF2,Colony Stimulating Factor 2,Sargramostim,GMCSF,CSF,Granulocyte Macrophage-Colony Stimulating Factor,Granulocyte-Macrophage Colony Stimulating Factor,Colony-Stimulating Factor,Granulocyte-Macrophage Colony-Stimulating Factor,Colony Stimulating Factor 2 (Granulocyte-Macrophage),Molgramostim
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:9
Lastest Research Phase:NDA/BLA

Product ListCompare or Buy

Part of Bioactivity data

GMF-H4214-Cell-based assay
Human FcRn Heterodimer Protein Cell_Base

The bio-activity was determined by dose-dependent stimulation of the proliferation of TF-1 cells. The ED50 < 0.1 ng/mL, corresponding to a specific activity of > 1x107 Unit/mg.

GMF-H8214-BLI
Human_FcRn_Heterodimer_Protein_Bli

Loaded Biotinylated Human GM-CSF, epitope tag free, primary amine labeling (Cat. No. GMF-H8214) on SA Biosensor, can bind Human GM-CSF R alpha, His Tag (SPR verified) (Cat. No. GRA-H52H7) with an affinity constant of 23.1 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

GMF-H4214-BLI
Human_FcRn_Heterodimer_Protein_Bli

Loaded Human GM-CSF R alpha, Fc Tag (Cat. No. GRA-H5255) on Protein A Biosensor, can bind ActiveMax® Human GM-CSF, Tag Free (Cat. No. GMF-H4214) with an affinity constant of 9.21 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

Synonym Name

GM-CSF,CSF2,MGC131935

Background

Granulocyte-macrophage colony-stimulating factor (GM-CSF) is also known as Colony stimulating factor 2 (granulocyte-macrophage), is a cytokine initially characterized by its ability to induce colonies of granulocytes and macrophages from myeloid progenitor cells, and is secreted by macrophages, T cells, mast cells, endothelial cells and fibroblasts. GM-CSF is a cytokine that functions as a white blood cell growth factor. GM-CSF stimulates stem cells to produce granulocytes (neutrophils, eosinophils, and basophils) and monocytes. Monocytes exitthe circulation and migrate into tissue, whereupon they mature into macrophages and dendritic cells. Thus, it is part of the immune/inflammatory cascade, by which activation of a small number of macrophages can rapidly lead to an increase in their numbers, a process crucial for fighting infection. The active form of the protein is found extracellularly as a homodimer. Human GM-CSF glycosylated in its mature form. As a part of the immune/inflammatory cascade, GM-CSF promotes Th1 biased immune response, angiogenesis, allergic inflammation, and the development of autoimmunity, and thus worthy of consideration for therapeutic target. GM-CSF has also recently been evaluated in clinical trials for its potential as a vaccine adjuvant in HIV-infected patients. The preliminary results have been promising. GM-CSF is also used as a medication to stimulate the production of white blood cells following chemotherapy.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Otilimab MOR-103; MOR-04357; GSK-3196165; GSK-165 Phase 3 Clinical University Of Melbourne Arthritis, Rheumatoid; Multiple Sclerosis; Severe Acute Respiratory Syndrome; Glycogen Storage Disease Type II; Osteoarthritis Details
BT-001 BT-001 Phase 2 Clinical Transgene Solid tumours; Carcinoma, Merkel Cell; Triple Negative Breast Neoplasms; Neoplasms; Sarcoma; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Melanoma Details
PBI-1402 PBI-1402 Phase 2 Clinical Prometic Life Sciences Anemia Details
PD-360324 PD-360324; PD-0360324 Phase 2 Clinical Pfizer Pharmaceuticals Ltd (China) Neoplasms; Lupus Erythematosus, Cutaneous; Sarcoidosis, Pulmonary Details
Plonmarlimab TJ-003234RAR101; TJM-2; TJ-003234 Phase 3 Clinical I-Mab Biopharma Co Ltd Coronavirus Disease 2019 (COVID-19); Arthritis, Rheumatoid Details
Gimsilumab MORAb-022; KIN-1901 Phase 2 Clinical Morphotek Coronavirus Disease 2019 (COVID-19); Arthritis, Rheumatoid; Nasopharyngeal Neoplasms; Rheumatic Diseases; Inflammation Details
Pexastimogene devacirepvec TG-6006; JX-594 Phase 3 Clinical Sillajen, Regeneron Pharmaceuticals Inc, National Cancer Institute, Samsung Medical Center & Samsung Electronics Devices Llc Liver Neoplasms; Rhabdomyosarcoma; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Wilms Tumor; Neuroblastoma; Sarcoma, Ewing; Colorectal Neoplasms; Lung Neoplasms; Lymphoma; Carcinoma, Hepatocellular; Melanoma Details
Bi-shRNAfurin and GMCSF augmented autologous tumor cell immunotherapy (Gradalis/Mary Crowley) IND-14205 Phase 3 Clinical Gradalis Ovarian Neoplasms; Liver Neoplasms; Colonic Neoplasms; Sarcoma, Ewing; Breast Neoplasms; Genital Neoplasms, Female; Lung Neoplasms; Uterine Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms Details
Namilumab MT-203; AMG-203; IZN-101 Phase 2 Clinical Takeda Pharmaceutical Co Ltd, Amgen Inc Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis Details
Vusolimogene oderparepvec RP-1 Phase 2 Clinical Replimune Skin Melanoma; Carcinoma, Merkel Cell; Skin Neoplasms; Basal Cell Nevus Syndrome; Microsatellite Instability; Carcinoma, Squamous Cell; Melanoma; Carcinoma, Non-Small-Cell Lung Details
SAR-441000 SAR441000; SAR-441000; BNT-131 Phase 1 Clinical Biontech Se, Sanofi Neoplasm Metastasis Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America: +1 800-810-0816 (Toll Free)
Asia & Pacific: +86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message